A citation-based method for searching scientific literature

Baptiste Eluard, Stéphanie Nuan-Aliman, Nathalie Faumont, Davi Collares, Didier Bordereaux, Aurélie Montagne, Isabelle Martins, Nicolas Cagnard, Martial Caly, Oussama Taoui, Leonardo Lordello, Jacqueline Lehmann-Che, Bruno Tesson, Jose-Angel Martinez-Climent, Christiane Copie-Bergman, Corinne Haioun, Hervé Tilly, Benjamin Bonsang, Anne Vincent-Salomon, Jean-Philippe Jais, Fabrice Jardin, Karen Leroy, Maria Chiara Maiuri, Guido Kroemer, Thierry Jo Molina, Jean Feuillard, Véronique Baud. Blood 2022
Times Cited: 8







List of co-cited articles
107 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.
A A Beg, W C Sha, R T Bronson, S Ghosh, D Baltimore. Nature 1995
50

Oncogenic activation of NF-kappaB.
Louis M Staudt. Cold Spring Harb Perspect Biol 2010
379
50


Inflammation meets cancer, with NF-κB as the matchmaker.
Yinon Ben-Neriah, Michael Karin. Nat Immunol 2011
37

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.
D C Guttridge, C Albanese, J Y Reuther, R G Pestell, A S Baldwin. Mol Cell Biol 1999
37

CARD-BCL-10-MALT1 signalling in protective and pathological immunity.
Jürgen Ruland, Lara Hartjes. Nat Rev Immunol 2019
89
37

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
881
37

Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.
Ryan M Young, James D Phelan, Wyndham H Wilson, Louis M Staudt. Immunol Rev 2019
49
37

The noncanonical NF-κB pathway.
Shao-Cong Sun. Immunol Rev 2012
473
37

A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
James D Phelan, Ryan M Young, Daniel E Webster, Sandrine Roulland, George W Wright, Monica Kasbekar, Arthur L Shaffer, Michele Ceribelli, James Q Wang, Roland Schmitz,[...]. Nature 2018
180
37

NF-κB, inflammation, immunity and cancer: coming of age.
Koji Taniguchi, Michael Karin. Nat Rev Immunol 2018
37

Molecular biology of Hodgkin lymphoma.
Marc A Weniger, Ralf Küppers. Leukemia 2021
38
37

Initial genome sequencing and analysis of multiple myeloma.
Michael A Chapman, Michael S Lawrence, Jonathan J Keats, Kristian Cibulskis, Carrie Sougnez, Anna C Schinzel, Christina L Harview, Jean-Philippe Brunet, Gregory J Ahmann, Mazhar Adli,[...]. Nature 2011
37

NF-κB-inducing kinase is essential for B-cell maintenance in mice.
Matthias Hahn, Anna Macht, Ari Waisman, Nadine Hövelmeyer. Eur J Immunol 2016
28
37

Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development.
Nilushi S De Silva, Michael M Anderson, Amanda Carette, Kathryn Silva, Nicole Heise, Govind Bhagat, Ulf Klein. Proc Natl Acad Sci U S A 2016
49
37

Regulation and function of NF-kappaB transcription factors in the immune system.
Sivakumar Vallabhapurapu, Michael Karin. Annu Rev Immunol 2009
37

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.
Mara Compagno, Wei Keat Lim, Adina Grunn, Subhadra V Nandula, Manisha Brahmachary, Qiong Shen, Francesco Bertoni, Maurilio Ponzoni, Marta Scandurra, Andrea Califano,[...]. Nature 2009
775
37

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.
Véronique Baud, Michael Karin. Nat Rev Drug Discov 2009
798
37




NF-kappa B: a new player in angiostatic therapy.
Sebastien P Tabruyn, Arjan W Griffioen. Angiogenesis 2008
84
25

The NF-κB Pathway and Cancer Stem Cells.
Amanda L Rinkenbaugh, Albert S Baldwin. Cells 2016
150
25

Single cell whole genome sequencing reveals that NFKB1 mutation affects radiotherapy sensitivity in cervical cancer.
Dong Yang, Weiyuan Zhang, JunQing Liang, Kexin Ma, Peng Chen, Danni Lu, Wenjing Hao. Oncotarget 2017
9
25


Tumour necrosis factor and cancer.
Frances Balkwill. Nat Rev Cancer 2009
25

The interplay between EBV and KSHV viral products and NF-κB pathway in oncogenesis.
J Charostad, M Nakhaie, A Dehghani, E Faghihloo. Infect Agent Cancer 2020
10
25

Noncanonical NF-κB in Cancer.
Matthew Tegowski, Albert Baldwin. Biomedicines 2018
31
25

EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.
Thomas Grimm, Sabine Schneider, Elisabeth Naschberger, Jürgen Huber, Eric Guenzi, Arnd Kieser, Peter Reitmeir, Thomas F Schulz, Cindy A Morris, Michael Stürzl. Blood 2005
69
25


Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.
Dorothee Pflueger, Stéphane Terry, Andrea Sboner, Lukas Habegger, Raquel Esgueva, Pei-Chun Lin, Maria A Svensson, Naoki Kitabayashi, Benjamin J Moss, Theresa Y MacDonald,[...]. Genome Res 2011
150
25

Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements.
Ahmed Malki, Rasha Abu ElRuz, Ishita Gupta, Asma Allouch, Semir Vranic, Ala-Eddin Al Moustafa. Int J Mol Sci 2020
57
25

Genome reading by the NF-κB transcription factors.
Maria Carmen Mulero, Vivien Ya-Fan Wang, Tom Huxford, Gourisankar Ghosh. Nucleic Acids Res 2019
50
25

The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation.
Laura Tornatore, Anil K Thotakura, Jason Bennett, Marta Moretti, Guido Franzoso. Trends Cell Biol 2012
303
25

NFKBIA deletion in glioblastomas.
Markus Bredel, Denise M Scholtens, Ajay K Yadav, Angel A Alvarez, Jaclyn J Renfrow, James P Chandler, Irene L Y Yu, Maria S Carro, Fangping Dai, Michael J Tagge,[...]. N Engl J Med 2011
179
25

Genetic Alterations of TRAF Proteins in Human Cancers.
Sining Zhu, Juan Jin, Samantha Gokhale, Angeli M Lu, Haiyan Shan, Jianjun Feng, Ping Xie. Front Immunol 2018
50
25

Protein ubiquitination in lymphoid malignancies.
Yibin Yang, Louis M Staudt. Immunol Rev 2015
18
25

Unraveling the molecular mechanisms between inflammation and tumor angiogenesis.
Wenwen Zhou, Longtao Yang, Lin Nie, Hui Lin. Am J Cancer Res 2021
19
25

NF-κB dysregulation in multiple myeloma.
Geoffrey M Matthews, Ricardo de Matos Simoes, Eugen Dhimolea, Michal Sheffer, Sara Gandolfi, Olga Dashevsky, Jeffrey D Sorrell, Constantine S Mitsiades. Semin Cancer Biol 2016
35
25

NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
Larry Mansouri, Nikos Papakonstantinou, Stavroula Ntoufa, Kostas Stamatopoulos, Richard Rosenquist. Semin Cancer Biol 2016
54
25

Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Mélanie Juilland, Margot Thome. Curr Opin Hematol 2016
51
25


NF-kappaB-inducing kinase in cancer.
Gunter Maubach, Michael H Feige, Michelle C C Lim, Michael Naumann. Biochim Biophys Acta Rev Cancer 2019
19
25




Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB.
Chiara Porta, Monica Rimoldi, Geert Raes, Lea Brys, Pietro Ghezzi, Diana Di Liberto, Francesco Dieli, Serena Ghisletti, Gioacchino Natoli, Patrick De Baetselier,[...]. Proc Natl Acad Sci U S A 2009
439
25

Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes.
R Bessho, K Matsubara, M Kubota, K Kuwakado, H Hirota, Y Wakazono, Y W Lin, A Okuda, M Kawai, R Nishikomori. Biochem Pharmacol 1994
187
25


Expanding the View of IKK: New Substrates and New Biology.
Ricardo J Antonia, Robert S Hagan, Albert S Baldwin. Trends Cell Biol 2021
24
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.